The decrease of IL-8 in COPD was borderline significant, and Roflumilast did not change sputum IL-8 and MPO after allergen challenge in asthmatic patients [ 31 , 32 ].
← all excerpts
Low-dose endotoxin inhalation in healthy volunteers--a challenge model for early clinical drug development.
2
—
—
The sentences
With respect to the total sputum cell count and the neutrophil cell count, we observed the lowest values after Roflumilast treatment, but this decline did not reach statistical significance compared with the second LPS challenge.